AMD 3465

Drug Profile

AMD 3465

Latest Information Update: 23 Jul 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AnorMED; Rega Institute for Medical Research
  • Developer irsiCaixa Foundation
  • Class Antivirals; Pyridines
  • Mechanism of Action CXCR4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 23 Jul 1999 Discontinued-Preclinical for HIV infections treatment in Spain (Unknown route)
  • 04 Sep 1998 A study has been added to the antimicrobial activity section
  • 21 Jul 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top